As we better understand the acute challenges of managing the COVID-19 pandemic, it is the lingering effects on COVID-19 survivors that healthcare providers are increasingly beginning to treat. Initially viewed as a respiratory disease, it is now clearer that many organ systems are affected due to a systemic inflammatory response. Many COVID-19 survivors have sustained prolonged periods of sedation and immobilization, putting them at increased risk of myopathy and polyneuropathy. Emerging reports of neurological sequelae include nerve pain, confusion, headache, anosmia, and chronic fatigue. This course will shed light on some of these emerging symptoms and potential treatment solutions.